CPMD
CANNAPHARMARX, INC.Company Information
- Company Name
- CANNAPHARMARX, INC.
- CIK
- CIK0001081938
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CPMD: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CPMD
SEC filing data through
Insider Sentiment
- Last purchase
- 2019-01-02
- Last sale
- 2019-10-08
- Shares purchased (TTM)
- 600,000
- Shares sold (TTM)
- 1,000,000
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-18
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-03-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Series C Preferred Stock | - | 0 | 0 | 0 | -0 | 0 | 0 | - | 0 | - | ||||||
| Series D Preferred Stock | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Series B Preferred Stocks | - | 0 | 0 | - | - | - | 0 | - | - | - | ||||||
Assets | ||||||||||||||||
| Series B Preferred Stock | - | - | - | - | 0 | 0 | 0 | - | 0 | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Cash | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | - | - | 0 | ||||||
Assets Current | ||||||||||||||||
| Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Other Assets Current | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Income Taxes Receivable | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | - | - | - | 0 | - | 0 | - | ||||||
| Accounts Receivable Net | - | - | 0 | 1 | 0 | 0 | 0 | 0 | - | - | ||||||
| Inventory Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||
| Finance Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | 5 | ||||||
| Operating Lease Right Of Use Asset | 5 | 5 | 6 | 6 | 6 | 5 | 5 | 6 | 6 | - | ||||||
| Investments | - | - | 0 | 5 | 5 | 5 | 5 | 5 | 5 | 0 | ||||||
| Assets | 7 | 7 | 7 | 12 | 11 | 11 | 11 | 12 | 11 | 5 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||
| Bank Overdrafts | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 6 | 10 | 10 | 10 | 10 | 13 | 9 | - | - | - | ||||||
| Notes Payable | - | - | - | 0 | 0 | 0 | 7 | 7 | - | - | ||||||
| Other Accounts Payable And Accrued Liabilities | - | - | 5 | - | - | - | 1 | 9 | - | - | ||||||
| Accounts Payable Current | 10 | - | - | - | - | - | - | - | 8 | 8 | ||||||
| Interest Payable Current | 2 | 2 | 2 | - | - | - | 2 | - | 1 | 0 | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | - | - | 0 | 0 | - | - | - | ||||||
Liabilities Current | ||||||||||||||||
| Liabilities Current | 33 | 31 | 32 | 28 | 29 | 27 | 26 | 23 | 29 | 20 | ||||||
| Notes Payable Current | 0 | 0 | 0 | - | - | - | 7 | - | 3 | 8 | ||||||
| Litigation Reserve Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Convertible Notes Payable Current | - | 1 | 1 | - | - | - | 1 | - | - | - | ||||||
| Convertible Notes Payable | 1 | - | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Current | 3 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 9 | 1 | ||||||
| Accrued Royalties Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | - | - | - | 1 | - | - | - | ||||||
Liabilities Noncurrent | ||||||||||||||||
| Long Term Loans Payable | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 5 | 5 | 5 | - | - | - | 5 | - | - | - | ||||||
| Liabilities | 38 | 37 | 37 | 34 | 34 | 32 | 31 | 28 | 35 | 26 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||
| Stockholders Equity | -31 | -30 | -30 | -23 | -23 | -21 | -20 | -17 | -24 | -21 | ||||||
| Treasury Stock Common Value | - | - | - | - | - | 0 | 0 | 0 | - | - | ||||||
| Common Stock Shares Subscriptions | - | 0 | 0 | - | - | - | 0 | - | - | - | ||||||
| Additional Paid In Capital | 83 | 82 | 82 | 81 | 80 | 80 | 80 | 80 | 79 | 75 | ||||||
| Retained Earnings Accumulated Deficit | -115 | -113 | -112 | -105 | -103 | -102 | -101 | -97 | -103 | -99 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | 0 | -0 | 0 | -0 | 1 | 1 | 0 | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 7 | 7 | 7 | 12 | 11 | 11 | 11 | 12 | 11 | 5 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | ||||||
| Common Stock Shares Issued | 709 | 679 | 663 | 663 | 663 | 663 | 663 | 663 | 5 | 295 | ||||||
| Shares Outstanding | 709 | 679 | 663 | 663 | 663 | 663 | 663 | 663 | 560 | 295 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | 0.00 | - | - | ||||||
| Treasury Stock Common Shares | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Preferred Stock Shares Authorized | - | - | 3 | 3 | 3 | 3 | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | - | 1 | 1 | 1 | - | 1 | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCANNAPHARMARX, INC. (CPMD) — SEC Financial Statements & Analysis
CANNAPHARMARX, INC. (CPMD) is a pharmaceutical preparations company, incorporated in DE. CANNAPHARMARX, INC. trades on OTC as: CPMD. CANNAPHARMARX, INC. (CPMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-18. Based on that filing, CANNAPHARMARX, INC. carries a market cap of $1.64M, a P/E ratio of -0.14x, a P/B ratio of -0.05x, a P/S ratio of 0.96x, an enterprise value of $2.06M, and an EV/EBITDA multiple of -0.73x. On profitability, it posts a gross margin of -88.82%, an operating margin of -170.13%, a net margin of -666.22%, a Return on Equity (ROE) of 42.39%, and a Return on Assets (ROA) of -123.26%. Per share, it reports EPS of $-0.02, diluted EPS of $-0.02, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 24.81% year-over-year, net income growth of 3747.09% year-over-year, and EPS growth of 3634.46% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.00x, working capital of $-31.24M, a debt-to-equity ratio of -1.22x, a debt ratio of 5.47, an interest coverage ratio of -1.91x, free cash flow of $-167.40K (TTM), and net debt of $422.79K. Figures sourced from SEC EDGAR.
- Market Cap
- $1.64M
- P/E TTM
- -0.14x
- EPS TTM
- $-0.02
- P/B TTM
- -0.05x
- ROE TTM
- 42.39%
- ROA TTM
- -123.26%
- Debt To Equity
- -1.22x
- Free Cash Flow TTM
- $-167.40K
- Net Revenue TTM Growth 1Y
- 24.81%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CANNAPHARMARX, INC. in?
CANNAPHARMARX, INC. (CPMD) operates in the Pharmaceutical Preparations industry.
What exchange does CPMD trade on?
CANNAPHARMARX, INC. (CPMD) trades on the OTC.
Where is CANNAPHARMARX, INC. incorporated?
CANNAPHARMARX, INC. is incorporated in DE.
When was CANNAPHARMARX, INC. (CPMD)'s most recent SEC filing?
CANNAPHARMARX, INC. (CPMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-18.
What is CPMD's market cap?
CANNAPHARMARX, INC. (CPMD) has a market capitalization of $1.64M as of 2026-06-30.
What is CPMD's EPS (earnings per share)?
CANNAPHARMARX, INC. (CPMD)'s trailing twelve month EPS is $-0.02 as of 2026-06-30.
What is CPMD's ROE (return on equity)?
CANNAPHARMARX, INC. (CPMD)'s trailing twelve month Return on Equity (ROE) is 42.39% as of 2026-06-30.
What is CPMD's ROA (return on assets)?
CANNAPHARMARX, INC. (CPMD)'s trailing twelve month Return on Assets (ROA) is -123.26% as of 2026-06-30.
What is CPMD's EV/EBITDA?
CANNAPHARMARX, INC. (CPMD)'s trailing twelve month EV/EBITDA is -0.73x as of 2026-06-30.